Cookson Peirce & CO Inc Crispr Therapeutics Ag Transaction History

Cookson Peirce & CO Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$38.62 - $72.18 $240,023 - $448,598	6,215 New	6,215 $389,000
Q2 2022 Jul 20, 2022	BUY	$43.23 - $73.83 $768,759 - $1.31 Million	17,783 New	17,783 $1.08 Million
Q4 2021 Jan 31, 2022	SELL	$70.09 - $111.29 $1.06 Million - $1.68 Million	-15,053 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$110.2 - $156.64 $190,205 - $270,360	1,726 Added 12.95%	15,053 $1.68 Million
Q2 2021 Aug 03, 2021	BUY	$100.84 - $161.89 $1.34 Million - $2.16 Million	13,327 New	13,327 $2.16 Million
Q1 2021 May 11, 2021	SELL	$110.72 - $210.04 $1.9 Million - $3.61 Million	-17,183 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$79.67 - $173.23 $122,612 - $266,600	1,539 Added 9.84%	17,183 $2.63 Million
Q3 2020 Nov 04, 2020	BUY	$78.5 - $100.64 $349,011 - $447,445	4,446 Added 39.7%	15,644 $1.31 Million
Q2 2020 Aug 07, 2020	BUY	$38.5 - $76.05 $63,602 - $125,634	1,652 Added 17.31%	11,198 $822,000
Q1 2020 May 04, 2020	BUY	$33.68 - $62.53 $321,509 - $596,911	9,546 New	9,546 $404,000
Q3 2019 Nov 05, 2019	SELL	$40.99 - $52.56 $332,223 - $425,998	-8,105 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$35.45 - $48.2 $287,322 - $390,661	8,105 New	8,105 $0
Q1 2019 May 01, 2019	SELL	$28.02 - $40.87 $213,512 - $311,429	-7,620 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$22.73 - $42.34 $173,202 - $322,630	7,620 New	7,620 $217,000

486

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.